Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: A pooled analysis of 3 population-based case-control studies

Qing Lan, Lindsay M. Morton, Bruce Armstrong, Patricia Hartge, Idan Menashe, Tongzhang Zheng, Mark P. Purdue, James R Cerhan, Yawei Zhang, Andrew Grulich, Wendy Cozen, Meredith Yeager, Theodore R. Holford, Claire M. Vajdic, Scott Davis, Brian Leaderer, Anne Kricker, Maryjean Schenk, Shelia H. Zahm, Nilanjan ChatterjeeStephen J. Chanock, Nathaniel Rothman, Sophia S. Wang

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Caspases play a critical role in regulation of apoptosis, cell differentiation, inflammation, and innate immunity, and several are mutated or have altered expression in non-Hodgkin lymphoma (NHL). To study the impact of genetic variation in caspases on NHL risk, we analyzed tag single nucleotide polymorphisms (SNPs) in 12 caspase and related genes in 3 population-based case-control studies (1946 cases and 1808 controls). Gene-based analysis, adjusting for the number of tagSNPs genotyped in each gene, showed significant associations for CASP8, CASP9, and CASP1. SNP-based analysis showed that CASP8 rs6736233 (odds ratio (OR) CG = 1.21; ORCC = 2.13; P trend = .011); CASP9 rs4661636 (ORCT = 0.89; ORTT = 0.77; P trend = .011); and CASP1 rs1785882 (ORAT = 1.12; ORAA = 1.30; P trend = .0054) were significantly associated with NHL risk and consistent across studies. It is noteworthy that genetic variants in CASP8 were associated with risk of all major NHL subtypes. Our findings suggest that genetic variation in caspases may play an important role in lymphomagenesis.

Original languageEnglish (US)
Pages (from-to)264-267
Number of pages4
JournalBlood
Volume114
Issue number2
DOIs
StatePublished - 2009

Fingerprint

Caspases
Non-Hodgkin's Lymphoma
Case-Control Studies
Genes
Polymorphism
Nucleotides
Caspase 12
Population
Single Nucleotide Polymorphism
Innate Immunity
Apoptosis
Cell Differentiation
Odds Ratio
Inflammation

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Lan, Q., Morton, L. M., Armstrong, B., Hartge, P., Menashe, I., Zheng, T., ... Wang, S. S. (2009). Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: A pooled analysis of 3 population-based case-control studies. Blood, 114(2), 264-267. https://doi.org/10.1182/blood-2009-01-198697

Genetic variation in caspase genes and risk of non-Hodgkin lymphoma : A pooled analysis of 3 population-based case-control studies. / Lan, Qing; Morton, Lindsay M.; Armstrong, Bruce; Hartge, Patricia; Menashe, Idan; Zheng, Tongzhang; Purdue, Mark P.; Cerhan, James R; Zhang, Yawei; Grulich, Andrew; Cozen, Wendy; Yeager, Meredith; Holford, Theodore R.; Vajdic, Claire M.; Davis, Scott; Leaderer, Brian; Kricker, Anne; Schenk, Maryjean; Zahm, Shelia H.; Chatterjee, Nilanjan; Chanock, Stephen J.; Rothman, Nathaniel; Wang, Sophia S.

In: Blood, Vol. 114, No. 2, 2009, p. 264-267.

Research output: Contribution to journalArticle

Lan, Q, Morton, LM, Armstrong, B, Hartge, P, Menashe, I, Zheng, T, Purdue, MP, Cerhan, JR, Zhang, Y, Grulich, A, Cozen, W, Yeager, M, Holford, TR, Vajdic, CM, Davis, S, Leaderer, B, Kricker, A, Schenk, M, Zahm, SH, Chatterjee, N, Chanock, SJ, Rothman, N & Wang, SS 2009, 'Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: A pooled analysis of 3 population-based case-control studies', Blood, vol. 114, no. 2, pp. 264-267. https://doi.org/10.1182/blood-2009-01-198697
Lan, Qing ; Morton, Lindsay M. ; Armstrong, Bruce ; Hartge, Patricia ; Menashe, Idan ; Zheng, Tongzhang ; Purdue, Mark P. ; Cerhan, James R ; Zhang, Yawei ; Grulich, Andrew ; Cozen, Wendy ; Yeager, Meredith ; Holford, Theodore R. ; Vajdic, Claire M. ; Davis, Scott ; Leaderer, Brian ; Kricker, Anne ; Schenk, Maryjean ; Zahm, Shelia H. ; Chatterjee, Nilanjan ; Chanock, Stephen J. ; Rothman, Nathaniel ; Wang, Sophia S. / Genetic variation in caspase genes and risk of non-Hodgkin lymphoma : A pooled analysis of 3 population-based case-control studies. In: Blood. 2009 ; Vol. 114, No. 2. pp. 264-267.
@article{347bc81e8aaf49438bcf84ce6f4cca6c,
title = "Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: A pooled analysis of 3 population-based case-control studies",
abstract = "Caspases play a critical role in regulation of apoptosis, cell differentiation, inflammation, and innate immunity, and several are mutated or have altered expression in non-Hodgkin lymphoma (NHL). To study the impact of genetic variation in caspases on NHL risk, we analyzed tag single nucleotide polymorphisms (SNPs) in 12 caspase and related genes in 3 population-based case-control studies (1946 cases and 1808 controls). Gene-based analysis, adjusting for the number of tagSNPs genotyped in each gene, showed significant associations for CASP8, CASP9, and CASP1. SNP-based analysis showed that CASP8 rs6736233 (odds ratio (OR) CG = 1.21; ORCC = 2.13; P trend = .011); CASP9 rs4661636 (ORCT = 0.89; ORTT = 0.77; P trend = .011); and CASP1 rs1785882 (ORAT = 1.12; ORAA = 1.30; P trend = .0054) were significantly associated with NHL risk and consistent across studies. It is noteworthy that genetic variants in CASP8 were associated with risk of all major NHL subtypes. Our findings suggest that genetic variation in caspases may play an important role in lymphomagenesis.",
author = "Qing Lan and Morton, {Lindsay M.} and Bruce Armstrong and Patricia Hartge and Idan Menashe and Tongzhang Zheng and Purdue, {Mark P.} and Cerhan, {James R} and Yawei Zhang and Andrew Grulich and Wendy Cozen and Meredith Yeager and Holford, {Theodore R.} and Vajdic, {Claire M.} and Scott Davis and Brian Leaderer and Anne Kricker and Maryjean Schenk and Zahm, {Shelia H.} and Nilanjan Chatterjee and Chanock, {Stephen J.} and Nathaniel Rothman and Wang, {Sophia S.}",
year = "2009",
doi = "10.1182/blood-2009-01-198697",
language = "English (US)",
volume = "114",
pages = "264--267",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "2",

}

TY - JOUR

T1 - Genetic variation in caspase genes and risk of non-Hodgkin lymphoma

T2 - A pooled analysis of 3 population-based case-control studies

AU - Lan, Qing

AU - Morton, Lindsay M.

AU - Armstrong, Bruce

AU - Hartge, Patricia

AU - Menashe, Idan

AU - Zheng, Tongzhang

AU - Purdue, Mark P.

AU - Cerhan, James R

AU - Zhang, Yawei

AU - Grulich, Andrew

AU - Cozen, Wendy

AU - Yeager, Meredith

AU - Holford, Theodore R.

AU - Vajdic, Claire M.

AU - Davis, Scott

AU - Leaderer, Brian

AU - Kricker, Anne

AU - Schenk, Maryjean

AU - Zahm, Shelia H.

AU - Chatterjee, Nilanjan

AU - Chanock, Stephen J.

AU - Rothman, Nathaniel

AU - Wang, Sophia S.

PY - 2009

Y1 - 2009

N2 - Caspases play a critical role in regulation of apoptosis, cell differentiation, inflammation, and innate immunity, and several are mutated or have altered expression in non-Hodgkin lymphoma (NHL). To study the impact of genetic variation in caspases on NHL risk, we analyzed tag single nucleotide polymorphisms (SNPs) in 12 caspase and related genes in 3 population-based case-control studies (1946 cases and 1808 controls). Gene-based analysis, adjusting for the number of tagSNPs genotyped in each gene, showed significant associations for CASP8, CASP9, and CASP1. SNP-based analysis showed that CASP8 rs6736233 (odds ratio (OR) CG = 1.21; ORCC = 2.13; P trend = .011); CASP9 rs4661636 (ORCT = 0.89; ORTT = 0.77; P trend = .011); and CASP1 rs1785882 (ORAT = 1.12; ORAA = 1.30; P trend = .0054) were significantly associated with NHL risk and consistent across studies. It is noteworthy that genetic variants in CASP8 were associated with risk of all major NHL subtypes. Our findings suggest that genetic variation in caspases may play an important role in lymphomagenesis.

AB - Caspases play a critical role in regulation of apoptosis, cell differentiation, inflammation, and innate immunity, and several are mutated or have altered expression in non-Hodgkin lymphoma (NHL). To study the impact of genetic variation in caspases on NHL risk, we analyzed tag single nucleotide polymorphisms (SNPs) in 12 caspase and related genes in 3 population-based case-control studies (1946 cases and 1808 controls). Gene-based analysis, adjusting for the number of tagSNPs genotyped in each gene, showed significant associations for CASP8, CASP9, and CASP1. SNP-based analysis showed that CASP8 rs6736233 (odds ratio (OR) CG = 1.21; ORCC = 2.13; P trend = .011); CASP9 rs4661636 (ORCT = 0.89; ORTT = 0.77; P trend = .011); and CASP1 rs1785882 (ORAT = 1.12; ORAA = 1.30; P trend = .0054) were significantly associated with NHL risk and consistent across studies. It is noteworthy that genetic variants in CASP8 were associated with risk of all major NHL subtypes. Our findings suggest that genetic variation in caspases may play an important role in lymphomagenesis.

UR - http://www.scopus.com/inward/record.url?scp=67651089850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651089850&partnerID=8YFLogxK

U2 - 10.1182/blood-2009-01-198697

DO - 10.1182/blood-2009-01-198697

M3 - Article

C2 - 19414860

AN - SCOPUS:67651089850

VL - 114

SP - 264

EP - 267

JO - Blood

JF - Blood

SN - 0006-4971

IS - 2

ER -